These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 32485321)
1. Folate targeted lipid chitosan hybrid nanoparticles for enhanced anti-tumor efficacy. Khan MM; Madni A; Filipczak N; Pan J; Rehman M; Rai N; Attia SA; Torchilin VP Nanomedicine; 2020 Aug; 28():102228. PubMed ID: 32485321 [TBL] [Abstract][Full Text] [Related]
2. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles. Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215 [TBL] [Abstract][Full Text] [Related]
3. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery. Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136 [TBL] [Abstract][Full Text] [Related]
4. Folate-modified, indocyanine green-loaded lipid-polymer hybrid nanoparticles for targeted delivery of cisplatin. Gu L; Shi T; Sun Y; You C; Wang S; Wen G; Chen L; Zhang X; Zhu J; Sun B J Biomater Sci Polym Ed; 2017 May; 28(7):690-702. PubMed ID: 28277002 [TBL] [Abstract][Full Text] [Related]
5. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
6. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin. Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells. Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023 [TBL] [Abstract][Full Text] [Related]
8. Folate decorated lipid chitosan hybrid nanoparticles of 5-fluorouracil for enhanced anticancer efficacy against colon cancer. Khan S; Madni A; Shah H; Jan N; Shafiq A; Basit A; Rai N; Ali A; Khan MM Int J Biol Macromol; 2022 Dec; 222(Pt A):497-508. PubMed ID: 36174854 [TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of folate conjugated N-trimethyl chitosan nanoparticles as protein carrier targeting folate receptor: in vitro studies. Zheng Y; Cai Z; Song X; Chen Q; Bi Y; Li Y; Hou S J Drug Target; 2009 May; 17(4):294-303. PubMed ID: 19255895 [TBL] [Abstract][Full Text] [Related]
10. Development of (153) Sm-folate-polyethyleneimine-conjugated chitosan nanoparticles for targeted therapy. Mollarazi E; Jalilian AR; Johari-Daha F; Atyabi F J Labelled Comp Radiopharm; 2015 Jun; 58(8):327-35. PubMed ID: 26036233 [TBL] [Abstract][Full Text] [Related]
11. Conjugates of TAT and folate with DOX-loaded chitosan micelles offer effective intracellular delivery ability. Zhang S; Liu Y; Gan Y; Qiu N; Gu Y; Zhu H Pharm Dev Technol; 2019 Feb; 24(2):253-261. PubMed ID: 29688120 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment. Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251 [TBL] [Abstract][Full Text] [Related]
13. Folate functionalized chitosan nanoparticles as targeted delivery systems for improved anticancer efficiency of cytarabine in MCF-7 human breast cancer cell lines. Geethakumari D; Bhaskaran Sathyabhama A; Raji Sathyan K; Mohandas D; Somasekharan JV; Thavarool Puthiyedathu S Int J Biol Macromol; 2022 Feb; 199():150-161. PubMed ID: 34973988 [TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity Enhancement of α-Mangostin with Folate-Conjugated Chitosan Nanoparticles in MCF-7 Breast Cancer Cells. Herdiana Y; Wathoni N; Shamsuddin S; Muchtaridi M Molecules; 2023 Nov; 28(22):. PubMed ID: 38005306 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier]. Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352 [TBL] [Abstract][Full Text] [Related]
16. Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel. Liu Y; Li K; Pan J; Liu B; Feng SS Biomaterials; 2010 Jan; 31(2):330-8. PubMed ID: 19783040 [TBL] [Abstract][Full Text] [Related]
17. Folate-targeted multifunctional amino acid-chitosan nanoparticles for improved cancer therapy. Gaspar VM; Costa EC; Queiroz JA; Pichon C; Sousa F; Correia IJ Pharm Res; 2015 Feb; 32(2):562-77. PubMed ID: 25186437 [TBL] [Abstract][Full Text] [Related]
18. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells. Yang SJ; Lin FH; Tsai KC; Wei MF; Tsai HM; Wong JM; Shieh MJ Bioconjug Chem; 2010 Apr; 21(4):679-89. PubMed ID: 20222677 [TBL] [Abstract][Full Text] [Related]
19. Role of folate-conjugated glycol-chitosan nanoparticles in modulating the activated macrophages to ameliorate inflammatory arthritis: in vitro and in vivo activities. Kumar V; Leekha A; Kaul A; Mishra AK; Verma AK Drug Deliv Transl Res; 2020 Aug; 10(4):1057-1075. PubMed ID: 32363539 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells. Li P; Wang Y; Zeng F; Chen L; Peng Z; Kong LX Carbohydr Res; 2011 May; 346(6):801-6. PubMed ID: 21397214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]